Literature DB >> 24406427

Are the anatomical sites for vaccine administration selected judiciously?

Basant Malik1, Goutam Rath1, Amit K Goyal2.   

Abstract

Route of vaccine administration plays an important role in the development of immune response. Antigen administered via different anatomical sites interacts with diverse subsets of antigen presenting cells. Diverse population of antigen presenting cells directs a drastically different immune response. Initially, the recommended routes for vaccine administration were also selected on the basis of clinical trials conducted for the drug molecules. However, physicochemical and pharmaceutical behaviors of proteins (antigens) and chemical compounds are entirely different. Most of the commercial vaccines are injected in the arm or in the scapular region (deltoid muscle). Vaccine administered to these conventional anatomical sites has failed to induce desired immune response due to lack of optimum level of antigen presenting cells. In this review, we have discussed the importance of the selection of anatomical sites for vaccine administration. Mere selection of an optimum site for vaccine administration may drastically change the immune response of the current marketed formulations without any alteration in their existing production plans.
Copyright © 2013 Elsevier B.V. All rights reserved.

Keywords:  Anatomical site; Antigen presentation; Dendritic cell; Topical vaccine; Vaccine

Mesh:

Substances:

Year:  2014        PMID: 24406427     DOI: 10.1016/j.intimp.2013.12.023

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  7 in total

Review 1.  Effect of vaccine administration modality on immunogenicity and efficacy.

Authors:  Lu Zhang; Wei Wang; Shixia Wang
Journal:  Expert Rev Vaccines       Date:  2015-08-27       Impact factor: 5.217

2.  Mouse dendritic cell migration in abdominal lymph nodes by intraperitoneal administration.

Authors:  Bin Wang; Chong Sun; Sijia Wang; Na Shang; Junjie Shangguan; Matteo Figini; Liang Pan; Kang Zhou; Quanhong Ma; Daniele Procissi; Yury Velichko; Vahid Yaghmai; Guoxin Li; Zhuoli Zhang
Journal:  Am J Transl Res       Date:  2018-09-15       Impact factor: 4.060

3.  Antigen-bearing outer membrane vesicles as tumour vaccines produced in situ by ingested genetically engineered bacteria.

Authors:  Yale Yue; Jiaqi Xu; Yao Li; Keman Cheng; Qingqing Feng; Xiaotu Ma; Nana Ma; Tianjiao Zhang; Xinwei Wang; Xiao Zhao; Guangjun Nie
Journal:  Nat Biomed Eng       Date:  2022-05-02       Impact factor: 29.234

Review 4.  Image-guided dendritic cell-based vaccine immunotherapy in murine carcinoma models.

Authors:  Bin Wang; Chong Sun; Sijia Wang; Na Shang; Matteo Figini; Quanhong Ma; Shanzhi Gu; Daniele Procissi; Vahid Yaghmai; Guoxin Li; Andrew Larson; Zhuoli Zhang
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

Review 5.  Immunogenicity of infectious pathogens and vaccine antigens.

Authors:  Siddhartha Mahanty; Antoine Prigent; Olivier Garraud
Journal:  BMC Immunol       Date:  2015-05-29       Impact factor: 3.615

6.  Inactivated Eyedrop Influenza Vaccine Adjuvanted with Poly(I:C) Is Safe and Effective for Inducing Protective Systemic and Mucosal Immunity.

Authors:  Eun-Do Kim; Soo Jung Han; Young-Ho Byun; Sang Chul Yoon; Kyoung Sub Choi; Baik Lin Seong; Kyoung Yul Seo
Journal:  PLoS One       Date:  2015-09-10       Impact factor: 3.240

7.  Comparison of vaccination efficacy using live or ultraviolet-inactivated influenza viruses introduced by different routes in a mouse model.

Authors:  Kyeongbin Baek; Sony Maharjan; Madhav Akauliya; Bikash Thapa; Dongbum Kim; Jinsoo Kim; Minyoung Kim; Mijeong Kang; Suyeon Kim; Joon-Yong Bae; Keun-Wook Lee; Man-Seong Park; Younghee Lee; Hyung-Joo Kwon
Journal:  PLoS One       Date:  2022-10-10       Impact factor: 3.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.